Catatan efek · kuartal yang diarsipkan
BIOA
BioAge Labs Inc. · Healthcare · Biotechnology
16Pemegang yang dilacak
+1Δ pemegang
5.16MSaham yang dipegang
$30.36MNilai yang dilaporkan
+1Posisi baru
−0Keluar
Input momentum (manajer yang sebanding):
keluasan pemegang +6.7% ·
aliran saham +13.4% ·
posisi baru bersih +6.2%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 66 | +4 | 13.22M | $323.71M | +6 | −2 |
| Q1 2026 | 65 | +14 | 13.97M | $243.82M | +19 | −5 |
| Q4 2025 | 51 | +2 | 8.60M | $113.77M | +2 | — |
| Q3 2025 | 16 | +1 | 5.16M | $30.36M | +1 | — |
| Q2 2025 | 12 | +5 | 4.16M | $17.19M | +5 | — |
| Q1 2025 | 4 | 0 | 455.40K | $1.71M | +2 | −2 |
| Q4 2024 | 4 | -5 | 347.20K | $2.01M | +1 | −6 |
| Q3 2024 | 8 | +8 | 1.18M | $24.62M | +8 | — |
Siapa yang memegangnya · Q3 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 1.65M | +6.0% | $9.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (pasif) | 1.65M | +6.0% | $9.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (pasif) | 1.65M | +6.0% | $9.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (pasif) | 1.28M | -0.6% | $7.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (pasif) | 1.28M | -0.6% | $7.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasif) | 1.28M | -0.6% | $7.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 1.28M | -0.6% | $7.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 1.28M | -0.6% | $7.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Geode Capital Management ✦ (pasif) | 562.73K | +24.1% | $3.31M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Geode Capital Management ✦ (pasif) | 562.73K | +24.1% | $3.31M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Millennium Management ✦ | 306.55K | +749.8% | $1.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Morgan Stanley ✦ | 228.16K | — | $1.34M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Morgan Stanley ✦ | 228.16K | — | $1.34M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 228.16K | — | $1.34M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 228.16K | — | $1.34M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 228.16K | — | $1.34M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 228.16K | — | $1.34M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (pasif) | 198.11K | +23.2% | $1.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 174.20K | -23.2% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 143.00K | +60.1% | $840,840 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 114.06K | +4.1% | $670,690 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 114.06K | +4.1% | $670,690 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 104.28K | +54.7% | $613,172 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 99.67K | +54.3% | $586,054 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | Fidelity (FMR) ✦ | 91.12K | +17.5% | $535,774 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | Goldman Sachs Group ✦ | 89.68K | — | $527,306 | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Goldman Sachs Group ✦ | 89.68K | — | $527,306 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 73.70K | — | $433,332 | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 73.70K | — | $433,332 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 73.70K | — | $433,332 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 73.70K | — | $433,332 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 73.70K | — | $433,332 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 73.70K | — | $433,332 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 35.75K | +13.3% | $210,187 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 35.75K | +13.3% | $210,187 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 35.75K | +13.3% | $210,187 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 35.75K | +13.3% | $210,187 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 35.75K | +13.3% | $210,187 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | T. Rowe Price ✦ | 11.89K | Baru | $70,000 | 0.0% | New | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| T. Rowe Price | $70,000 | 0.0% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 143 pemegang, 34.12M saham, $588.17M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q3 2025 ·
Metodologi ·
Dapatkan ini melalui API